title: Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab.
authors.forename: I
authors.initials: I
authors.lastname: Bruns
authors.forename: F
authors.initials: F
authors.lastname: Fox
authors.forename: P
authors.initials: P
authors.lastname: Reinecke
authors.forename: G
authors.initials: G
authors.lastname: Kobbe
authors.forename: R
authors.initials: R
authors.lastname: Kronenwett
authors.forename: G
authors.initials: G
authors.lastname: Jung
authors.forename: R
authors.initials: R
authors.lastname: Haas
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab